Does Dr. MARIA TESSIE BEDUYA-PRINCER have financial conflicts of interest?

Dr. MARIA TESSIE BEDUYA-PRINCER (M.D.) has received a total of $493 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $493 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARIA TESSIE BEDUYA-PRINCER?

According to CMS Open Payments data, Dr. MARIA TESSIE BEDUYA-PRINCER received funding from ASTRAZENECA PHARMACEUTICALS ($262), NESTLE HEALTHCARE NUTRITION ($125), and BAYER HEALTHCARE PHARMACEUTICALS ($39).

Does Dr. MARIA TESSIE BEDUYA-PRINCER receive research grants or speaking fees?

Dr. MARIA TESSIE BEDUYA-PRINCER has received $493 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARIA TESSIE BEDUYA-PRINCER

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: LAS VEGAS, NV 89110

NPI Number: 1649249608

LIFETIME INDUSTRY VALUE

$493

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BEDUYA-PRINCER is a verified Internal Medicine practitioner based in LAS VEGAS, NV.

Between 2021 and 2024, Dr. BEDUYA-PRINCER had an overall industry promotional and research financial footprint of $493 as recorded in the federal CMS Open Payments database.

$493 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BEDUYA-PRINCER's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $262 (representing 53.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$262

53.2%

NESTLE HEALTHCARE NUTRITION

Rank 2

$125

25.4%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 3

$39

7.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.